Yahoo Canada Web Search

Search results

  1. Anne E. Wojcicki (/ wuːˈtʃɪtski / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.

  2. Sep 18, 2024 · Recent News. Anne Wojcicki (born July 28, 1973, San Mateo county, California) is an American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe. Wojcicki received a B.S. degree (1996) in biology from Yale University. She later worked as a researcher and as an investment analyst.

  3. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    Jun 1, 2023 · Anne Wojcicki is the cofounder and CEO of 23andMe, a pioneering direct-to-consumer genetics testing firm based in South San Francisco, California. In June 2021, 23andMe went public in a SPAC ...

  4. 2 days ago · Founder Anne Wojcicki races to rescue 23andMe on whatsapp (opens in a new window) Save. Stephanie Stacey and Ian Johnston in London and George Hammond in San Francisco. October 15 2024.

  5. Oct 5, 2024 · Last month, the seven independent directors of the board sent an open letter to Anne Wojcicki, the chief executive and co-founder of 23andMe, notifying her of their resignation while citing ...

  6. Sep 19, 2024 · The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private. In a Tuesday letter addressed to Wojcicki, the seven directors said they had yet to receive a “a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders” from the chief executive after months of ...

  7. People also ask

  8. Anne Wojcicki. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent a decade on Wall Street investing in ...

  1. People also search for